The Obesity Pipeline: Current Strategies in the Development of Anti-obesity Drugs

Overview

Journal Nat Rev Drug Discov

Specialty Pharmacology

Date 2006 Nov 3

PMID 17080028

Citations 52

Authors

Dunstan Cooke

Steve Bloom

Affiliations

Soon will be listed here.

Abstract

This review provides a summary of currently available pharmaceutical therapies for the treatment of obesity, along with an overview of the pipeline of products currently in development, and the key mechanisms on which the major development candidates are based. In particular, the recent increase in understanding of the role of gut peptides in energy homeostasis is highlighted as a promising source of potential future obesity therapies.

Citing Articles

Novel Therapeutic Approach for Obesity: Seaweeds as an Alternative Medicine with the Latest Conventional Therapy.

Yadav R, Nigam A, Mishra R, Gupta S, Chaudhary A, Khan S Med Sci (Basel). 2024; 12(4).

PMID: 39449411 PMC: 11503287. DOI: 10.3390/medsci12040055.

Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges.

Ashour M, Mabrouk M, Aboelnasr M, Beherei H, Tohamy K, Das D Pharmaceutics. 2023; 15(11).

PMID: 38004612 PMC: 10674714. DOI: 10.3390/pharmaceutics15112635.

α-Amylase, α-Glucosidase, Pancreatic Lipase, Xanthine Oxidase Inhibiting Activity of Extracts.

Kim J, Jang M, Park Y Mycobiology. 2023; 51(1):60-66.

PMID: 36846626 PMC: 9946297. DOI: 10.1080/12298093.2023.2176020.

A Review on Drug Induced Obesity and Rodent Experimental Models of Obesity in Animals.

Vangoori Y, Suresh B, Midde M, Anusha D, Uppala P Maedica (Bucur). 2022; 17(3):706-713.

PMID: 36540593 PMC: 9720657. DOI: 10.26574/maedica.2022.17.3.706.

Effects of the Antiobesity Drugs Aplex and Venera on Certain Biochemical and Physiological Indices in Obese Adult Male Albino Rats.

Elpasty S, Helal E, Algendy A, Yousef H Adv Pharmacol Pharm Sci. 2022; 2022:3776676.

PMID: 35445196 PMC: 9015866. DOI: 10.1155/2022/3776676.